Characterization of MET-N375S as an Activating Mutation in Squamous Cell Carcinoma of the Lung
10.1016/j.jtho.2016.11.624
Saved in:
Main Authors: | Kong, Li Ren, Salleh, Nur Afiqah Binte Mohamed, Tan, Tuan Zea, Kappei, Dennis, Gohz, Boon Cher |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Conference or Workshop Item |
Published: |
ELSEVIER SCIENCE INC
2024
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/247589 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma
by: Lim, S.M., et al.
Published: (2014) -
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
by: Bang, Yung-Jue, et al.
Published: (2022) -
OVERRIDING CISPLATIN RESISTANCE IN LUNG SQUAMOUS CELL CARCINOMA: INSIGHTS FROM COMBINATION WITH HDAC INHIBITOR
by: KONG LI REN
Published: (2014) -
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
by: Kong, Li Ren, et al.
Published: (2020) -
MiR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway
by: Tan, S., et al.
Published: (2014)